Pharmocann Global Ltd.
PMCN-M | TA
Overview
Corporate Details
- ISIN(s):
- IL0010968902
- LEI:
- Country:
- Israel
- Address:
- Horesh Haalonim 1, 3009500 Ramat Yishai
- Website:
- https://www.pharmocann.co.il
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pharmocann-M develops and markets medical cannabis-based products for therapeutic applications in Israel.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-02-17 18:43 |
Regulatory News Service
Changes in the company's name and security, effective as of February 19, 2025
|
Hebrew (modern) | 118.3 KB | |
| 2023-10-03 16:36 |
Regulatory News Service
Excellence will cease to operate as a market maker in the company's shares as o…
|
Hebrew (modern) | 118.8 KB | |
| 2020-08-23 11:39 |
Investor Presentation
Investors Presentation - August 2020
|
English | 20.2 MB | |
| 2020-08-23 11:39 |
Registration Form
Investors Presentation - August 2020
|
Russian | 42.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Financière de Tubize S.A. | Belgium | TUBAT | |
|
Fine Foods & Pharmaceuticals Ntm | Italy | FF | |
|
Flerie AB | Sweden | FLERIE | |
|
Friulchem | Italy | FCM | |
|
FRP ADVISORY GROUP PLC | United Kingdom | FRP | |
|
Fuji Pharma Co.,Ltd. | Japan | 4554 | |
|
FunPep Company Limited | Japan | 4881 | |
|
Fuso Pharmaceutical Industries,Ltd. | Japan | 4538 | |
|
Galderma Group AG | Switzerland | GALD | |
|
GlaxoSmithKline PLC | United Kingdom | GSK |